切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (03) : 221 -225. doi: 10.3877/cma.j.issn.2095-3232.2019.03.010

所属专题： 文献；

临床研究

吲哚氰绿荧光示踪技术在肝癌解剖性肝切除中的应用
姚舜禹1, 荚卫东1,†(), 葛勇胜1, 许戈良1, 马金良1   
  1. 1. 230001　合肥，中国科学技术大学附属第一医院肝脏外科　肝胆胰外科安徽省重点实验室
  • 收稿日期:2019-02-13 出版日期:2019-06-10
  • 通信作者: 荚卫东
  • 基金资助:
    2017年度安徽省重点研究与开发项目(1704a0802150)

Application of indocyanine green fluorescence imaging in anatomical hepatectomy for hepatocellular carcinoma

Shunyu Yao1, Weidong Jia1,†(), Yongsheng Ge1, Geliang Xu1, Jinliang Ma1   

  1. 1. Department of Hepatic Surgery, the First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, China
  • Received:2019-02-13 Published:2019-06-10
  • Corresponding author: Weidong Jia
  • About author:
    Corresponding author: Jia Weidong, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

姚舜禹, 荚卫东, 葛勇胜, 许戈良, 马金良. 吲哚氰绿荧光示踪技术在肝癌解剖性肝切除中的应用[J]. 中华肝脏外科手术学电子杂志, 2019, 08(03): 221-225.

Shunyu Yao, Weidong Jia, Yongsheng Ge, Geliang Xu, Jinliang Ma. Application of indocyanine green fluorescence imaging in anatomical hepatectomy for hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(03): 221-225.

目的

探讨吲哚氰绿（ICG）荧光示踪技术在肝细胞癌（肝癌）解剖性肝切除中的应用价值。

方法

本前瞻性研究对象为2017年6月至2018年7月在中国科学技术大学附属第一医院行解剖性肝切除的55例肝癌患者。患者均签署知情同意书，符合医学伦理学规定。按照随机数字表法随机分为ICG示踪组（28例）和对照组（27例）。其中ICG示踪组男23例，女5例；平均年龄（54±12）岁；应用ICG荧光染色示踪技术行解剖性肝切除。对照组男22例，女5例；年龄（58±12）岁；行常规解剖性肝切除。两组手术相关指标比较采用t检验或χ2检验。

结果

ICG示踪组手术时间为（245±62）min，明显长于对照组的（198±60）min（t=2.857，P<0.05）。ICG示踪组术中输血率7%（2/28），明显低于对照组的45%（12/22） （χ2=10.079，P<0.05）。ICG示踪组术后引流拔管时间、最高体温分别为（6.3±2.4） d、（37.7±0.4）℃，明显少于对照组的（8.4±4.4） d、（38.0±0.6）℃（t=-2.194，-2.179；P<0.05）。

结论

ICG荧光示踪技术可清楚界定肝切除范围，加速患者术后康复，可作为解剖性肝切除的一种辅助手段。

关键词: 癌，肝细胞, 吲哚氰绿, 荧光, 肝切除术
Objective

To investigate the application value of indocyanine green (ICG) fluorescence imaging in anatomical hepatectomy for hepatocellular carcinoma (HCC).

Methods

55 patients with HCC who underwent anatomical hepatectomy in the First Affiliated Hospital of University of Science and Technology of China from June 2017 to July 2018 were enrolled in this prospective study. The informed consents of all patients were obtained and the local ethical committee approval was received. According to the random number table method, all patients were randomly divided into ICG group (n=28) and control group (n=27). In ICG group, 23 patients were male and 5 female, aged (54±12) years on average. Anatomical hepatectomy was performed using ICG fluorescence imaging. In control group, 22 patients were male and 5 female, aged (58±12) years on average. Conventional anatomical hepatectomy was performed. The surgery-related parameters were statistically compared between two groups by using t test or Chi-square test.

Results

In ICG group, the operation time was (245±62) min, significantly longer than (198±60) min in control group (t=2.857, P<0.05). In ICG group, the percentage of intraoperative blood transfusion was 7% (2/28), significantly lower than 45% (12/22) in control group (χ2=10.079, P<0.05). In ICG group, the drainage extubation time was (6.3±2.4) d and the highest body temperature was (37.7±0.4)℃ respectively, significantly less than (8.4±4.4) d and (38.0±0.6)℃ in control group (t=-2.194, -2.179; P<0.05).

Conclusions

ICG fluorescence imaging can clearly define the range of liver resection and accelerate the postoperative rehabilitation of patients, which can serve as an auxiliary approach for anatomical hepatectomy.

Key words: Carcinoma, hepatocellular, Indocyanine green, Fluorescence, Hepatectomy
图1 一例ICG荧光引导下肝癌解剖性肝切除术
表1 ICG示踪组和对照组肝癌肝切除患者术前一般资料比较
临床参数 ICG示踪组 对照组 统计值 P值
男/女 23/5 22/5 χ2 =0.000 >0.05
年龄（岁，±s ） 54±12 58±12 t=-1.361 >0.05
肿瘤直径（cm，±s ） 6±3 8±4 t=-1.988 >0.05
HBsAg阳性（例） 21 22 χ2 =0.339 >0.05
HBV-DNA定量> 1 000 copies/ml（例） 13 12 χ2 =0.022 >0.05
肝硬化（例） 20 21 χ2 =0.292 >0.05
AFP阳性（例） 23 25 χ2 =0.574 >0.05
肝切除史（例） 2 1 χ2 =0.000 >0.05
表2 ICG示踪组和对照组肝癌肝切除患者围手术期相关指标比较（±s）
组别 例数 手术时间（min） 术后住院时间（d） 引流管拔管时间（d）
ICG示踪组 28 245±62 10±6 6.3±2.4
对照组 27 198±60 12±5 8.4±4.4
t值 ? 2.857 -1.357 -2.194
P值 ? 0.006 0.180 0.034
表3 ICG示踪组和对照组肝癌肝切除患者术后并发症发生情况比较（例）
组别 例数 出血 胆漏 腹腔积液 胸腔积液 并发症Clavien分级≥Ⅱ级
ICG示踪组 28 0 0 12 8 8
对照组 27 4 1 14 13 10
χ2值 ? - - 0.446 2.232 0.447
P值 ? 0.111 0.491 0.504 0.135 0.504
[1]
Bray F,Ferlay J,Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2]
段飞，李学民，陈靓，等．肝细胞癌精准肝切除术后早期肠内营养与联合营养支持治疗的前瞻性研究[J]．中华消化外科杂志，2017, 16(12):1191-1198.
[3]
李自慧，叶甲舟，陈洁，等．解剖性肝切除术对合并微血管侵犯的肝癌患者早期复发的影响[J]．中华肝胆外科杂志，2018, 24(1): 18-22.
[4]
Fan ST. Precise hepatectomy guided by the middle hepatic vein[J]. Hepatobiliary Pancreal Dis Int, 2007, 6(4):430-434.
[5]
方驰华，刘允怡，周伟平，等．数字医学技术在中国普通外科应用的十年回顾[J]．中华外科杂志，2017, 55(12):887-890.
[6]
Wei WX,Yang ZS,Lu LH, et al. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma[J]. Int J Surg, 2018(56):256-263.
[7]
Zhao H,Chen C,Gu S, et al. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: a propensity score matching analysis[J].J Gastroenterol Hepatol, 2017, 32(4):870-878.
[8]
Ryu T,Honda G,Kurata M, et al. Perioperative and oncological outcomes of laparoscopic anatomical hepatectomy for hepatocellular carcinoma introduced gradually in a single center[J]. Surg Endosc, 2018, 32(2):790-798.
[9]
Shindoh J,Mise Y,Satou S, et al. The intersegmental plane of the liver is not always flat--tricks for anatomical liver resection[J]. Ann Surg, 2010, 251(5):917-922.
[10]
Baiocchi GL,Diana M,Boni L. Indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery: state of the art and future directions[J]. World J Gastroenterol, 2018, 24(27):2921-2930.
[11]
Nguyen DP,Huber PM,Metzger TA, et al. A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection[J]. Eur Urol, 2016, 70(5):734-737.
[12]
Nakaseko Y,Ishizawa T,Saiura A. Fluorescence-guided surgery for liver tumors[J]. J Surg Oncol, 2018, 118(2):324-331.
[13]
Gotoh K,Yamada T,Ishikawa O, et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation[J]. J Surg Oncol, 2009, 100(1):75-79.
[14]
中华医学会数字医学分会，中国研究型医院学会数字医学临床外科专业委员会，中国图学学会医学图像与设备专业委员会，等．计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中的应用专家共识[J]．中国实用外科杂志，2017, 37(5): 531-538.
[15]
Ishizawa T,Saiura A,Kokudo N. Clinical application of indocyanine green-fluorescence imaging during hepatectomy[J]. Hepatobiliary Surg Nutr, 2016, 5(4):322-328.
[16]
Miyata A,Ishizawa T,Tani K, et al. Reappraisal of a dye-staining technique for anatomic hepatectomy by the concomitant use of indocyanine green fluorescence imaging[J]. J Am Coll Surg, 2015, 221(2):e27-36.
[17]
Terasawa M,Ishizawa T,Mise Y, et al. Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy[J]. Surg Endosc, 2017, 31(1):5111-5118.
[18]
王宏光．吲哚菁绿肝段染色在腹腔镜肝癌切除中应用及意义[J]．中国实用外科杂志，2018, 38(4):376-378.
[19]
姚舜禹，荚卫东，王润东，等．吲哚菁绿荧光融合影像引导精准右半肝切除治疗肝细胞癌临床研究[J]．中国实用外科杂志，2018, 38(4):430-434.
[20]
Kobayashi Y,Kawaguchi Y,Kobayashi K, et al. Portal vein territory identification using indocyanine green fluorescence imaging: technical details and short-term outcomes[J]. J Surg Oncol, 2017, 116(7):921-931.
[21]
Inoue Y,Arita J,Sakamoto T, et al. Anatomical liver resections guided by 3-dimensional parenchymal staining using fusion indocyanine green fluorescence imaging[J]. Ann Surg, 2015, 262(1):105-111.
[22]
Nishino H,Hatano E,Seo S, et al. Real-time navigation for liver surgery using projection mapping with indocyanine green fluorescence: development of the novel medical imaging projection system[J]. Ann Surg, 2018，267(6):1134-1140.
[23]
Ueno M,Hayami S,Sonomura T, et al. Indocyanine green fluorescence imaging techniques and interventional radiology during laparoscopic anatomical liver resection (with video)[J]. Surg Endosc, 2018, 32(2):1051-1055.
[24]
Aoki T,Murakami M,Koizumi T, et al. Determination of the surgical margin in laparoscopic liver resections using infrared indocyanine green fluorescence[J]. Langenbecks Arch Surg, 2018, DOI: 10.1007/s00423-018-1685-y[Epub ahead of print].
[25]
Tanaka M,Inoue Y,Mise Y, et al. Laparoscopic deroofing for polycystic liver disease using laparoscopic fusion indocyanine green fluorescence imaging[J]. Surg Endosc, 2016, 30(6):2620-2623.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[3] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[4] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[5] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[6] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[7] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[8] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[9] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[10] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[11] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[12] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[13] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[14] 李博, 胡刚, 邱文龙, 汤坚强, 王锡山. 多功能吲哚菁绿近红外荧光血管成像技术在腹腔镜直肠癌经自然腔道取标本手术（NOSES Ⅳ式）中的应用（附视频）[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 524-528.
[15] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号